参考文献/References:
[1] Zheng R,Zhang S,Zeng H,et al.Cancer incidence and mortality in China,2016[J].Journal of the National Cancer Center,2022,2(1):1-9.
[2] Lee CW,Yu MC,Wang CC,et al.Liver resection for hepatocellular carcinoma larger than 10 cm:A multi-institution long-term observational study[J].World Journal of Gastrointestinal Surgery,2021,13(5):476-492.
[3] 郭俊霞,魏晓华.乙肝肝硬化患者合并原发性肝癌的危险因素及预后分析[J].陕西医学杂志,2019,48(7):850-852.
[4] Schwartzentruber DJ,Lawson DH,Richards JM,et al.Gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma[J].New England Journal of Medicine,2011,364(22):2119-2127.
[5] Zhang J,Zhong Y,Zhang P,et al.Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis,cirrhosis,and hepatocellular carcinoma[J].Glycobiology,2019,29(3):242-259.
[6] 肖时湘,韩 涛,王媛媛,等.调节性T细胞在慢性肝病中的变化[J].陕西医学杂志,2010,39(7):831-833.
[7] Tran T,Blanc C,Granier C,et al.Therapeutic cancer vaccine:Building the future from lessons of the past[J].Seminars in Immunopathology,2019,41:69-85.
[8] Löffler MW,Mohr C,Bichmann L,et al.Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma[J].Genome Medicine,2019,11(1):28.
[9] Zhou J,Wang T,Zhang K.AFP-L3 for the diagnosis of early hepatocellular carcinoma:A meta-analysis[J].Medicine,2021,100(43):e27673.
[10] Cao D,Yang J,Dou K,et al.Alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in vitro[J].Human Immunology,2007,68(5):334-341.
[11] Butterfield LH,Economou JS,Gamblin TC,et al.Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients[J].Journal of Translational Medicine,2014,12(1):86.
[12] Butterfield LH,Antoni R,Dissette VB,et al.A phase Ⅰ/Ⅱ trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides[J].Clinical Cancer Research,2006,12(9):2817-2825.
[13] Nakagawa H,Mizukoshi E,Kobayashi E,et al.Association between high-avidity T-Cell receptors,induced by α-fetoprotein-derived peptides,and anti-tumor effects in patients with hepatocellular carcinoma[J].Gastroenterology,2017,152(6):1395-1406.
[14] Dong LQ,Peng LH,Ma LJ,et al.Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma[J].Journal of Hepatology,2020,72(5):896-908.
[15] Sawada Y,Yoshikawa T,Nobuoka D,et al.Phase Ⅰ trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma:Immunologic evidence and potential for improving overall survival[J].Clinical Cancer Research,2012,18(13):3686.
[16] Sawada Y,Yoshikawa T,Ofuji K,et al.Phase Ⅱ study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients[J].Oncoimmunology,2016,5(5):e1129483.
[17] Cirqueira CS,Felipe-Silva AS,Wakamatsu A,et al.Immunohistochemical assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma[J].Pathology & Oncology Research,2018,25:1363-1371.
[18] Mizukoshi E,Nakagawa H,Kitahara M,et al.Phase Ⅰ trial of multidrug resistance-associated protein 3-derived peptide in patients with hepatocellular carcinoma[J].Cancer Letters,2015,369(1):242-249.
[19] Fratta E,Coral S,Covre A,et al.The biology of cancer testis antigens:Putative function,regulation and therapeutic potential[J].Molecular Oncology,2011,5(2):164-182.
[20] Shang XY,Chen HS,Zhang HG,et al.The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients[J].Clinical Cancer Research,2004,10(20):6946-6955.
[21] Flecken T,Schmidt N,Hild S,et al.Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma[J].Hepatology,2014,59(4):1415-1426.
[22] Zerbini A,Pilli M,Soliani P,et al.Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+ cells in patients with hepatocellular carcinoma[J].Journal of Hepatology,2004,40(1):102-109.
[23] Bricard G,Bouzourene H,Martinet O,et al.Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma[J].Journal of Immunology,2005,174:1709-1716.
[24] 王盛民,侯新江,张 瑛.肿瘤免疫逃逸分子机制与中药多靶点[J].陕西中医,2003,22(9):836-837.
相似文献/References:
[1]张慧贤,马向明,付庆江,等.肝细胞癌患者血清IL-17细胞因子水平检测的临床意义[J].陕西医学杂志,2016,(10):1394.
[2]苏艳丽,冯 军.血栓弹力图和常规凝血四项检测在评估肝癌患者围术期凝血功能中的应用研究*[J].陕西医学杂志,2019,(7):846.
SU Yanli,FENG Jun..Application of thromboelastography and conventional coagulation in evaluating perioperative coagulation function in patients with liver cancer[J].,2019,(12):846.
[3]李玉龙,宗 伟,常素娥,等.微小RNA-195通过靶向BIRC5调控肝癌Hep3B细胞凋亡实验研究[J].陕西医学杂志,2022,51(3):270.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.002]
LI Yulong,ZONG Wei,CHANG Su'e,et al.Experimental study of miRNA-195 regulating apoptosis of hepatoma Hep3B cells by targeting BIRC5[J].,2022,51(12):270.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.002]
[4]曹振振,韩会会,杨文义.肝癌患者血清成纤维细胞生长因子21和富亮氨酸α2糖蛋白1表达情况及临床意义[J].陕西医学杂志,2023,52(3):305.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.013]
CAO Zhenzhen,HAN Huihui,YANG Wenyi.Expression of FGF21 and LRG1 in serum of patients with hepatocellular carcinoma and its clinical diagnostic value[J].,2023,52(12):305.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.013]
[5]董 勇,程 序,梁 晗,等.肝癌组织角蛋白23表达与患者临床病理特征及预后关系研究[J].陕西医学杂志,2023,52(6):756.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.026]
DONG Yong,CHENG Xu,LIANG Han,et al.Relationship between keratin 23 expression and clinicopathological features and prognosis of patients with hepatocellular carcinoma[J].,2023,52(12):756.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.026]
[6]濮忠建,杨 军,杨 帆,等.基于长链非编码RNA HOX转录反义RNA探讨次乌头原碱对人肝癌SK-Hep-1细胞自噬的影响实验研究[J].陕西医学杂志,2024,(6):754.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.007]
PU Zhongjian,YANG Jun,YANG Fan,et al.Effect of protopine on autophagy in human liver cancer SK-Hep-1 cells based on lncRNA HOTAIR[J].,2024,(12):754.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.007]
[7]吴 洁,田鑫越,秦耐宇,等.艾司氯胺酮对肝癌细胞恶性生物学行为的影响及作用机制实验研究[J].陕西医学杂志,2024,(8):1041.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.007]
WU Jie,TIAN Xinyue,QIN Naiyu,et al.Effect of esketamine on malignant biological behavior of hepatocellular carcinoma cells and its mechanism[J].,2024,(12):1041.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.007]